BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36992206)

  • 1. Equity-Informative Economic Evaluations of Vaccines: A Systematic Literature Review.
    Patikorn C; Cho JY; Lambach P; Hutubessy R; Chaiyakunapruk N
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).
    Gandhi G
    BMC Public Health; 2015 Nov; 15():1198. PubMed ID: 26621528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries.
    Boujaoude MA; Mirelman AJ; Dalziel K; Carvalho N
    Cost Eff Resour Alloc; 2018; 16():18. PubMed ID: 29796012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global economic evaluations of rotavirus vaccines: A systematic review.
    Kotirum S; Vutipongsatorn N; Kongpakwattana K; Hutubessy R; Chaiyakunapruk N
    Vaccine; 2017 Jun; 35(26):3364-3386. PubMed ID: 28504193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.
    Kim SY; Sweet S; Chang J; Goldie SJ
    BMC Infect Dis; 2011 Jun; 11():174. PubMed ID: 21679420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease.
    Taha MK; Martinon-Torres F; Köllges R; Bonanni P; Safadi MAP; Booy R; Smith V; Garcia S; Bekkat-Berkani R; Abitbol V
    Expert Rev Vaccines; 2022 May; 21(5):659-674. PubMed ID: 35271781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review.
    Chongmelaxme B; Hammanee M; Phooaphirak W; Kotirum S; Hutubessy R; Chaiyakunapruk N
    J Med Econ; 2017 Oct; 20(10):1094-1106. PubMed ID: 28737468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries.
    Deogaonkar R; Hutubessy R; van der Putten I; Evers S; Jit M
    BMC Public Health; 2012 Oct; 12():878. PubMed ID: 23072714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.
    Verguet S; Murphy S; Anderson B; Johansson KA; Glass R; Rheingans R
    Vaccine; 2013 Oct; 31(42):4902-10. PubMed ID: 23871824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries.
    Chang AY; Riumallo-Herl C; Perales NA; Clark S; Clark A; Constenla D; Garske T; Jackson ML; Jean K; Jit M; Jones EO; Li X; Suraratdecha C; Bullock O; Johnson H; Brenzel L; Verguet S
    Health Aff (Millwood); 2018 Feb; 37(2):316-324. PubMed ID: 29401021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine equity in low and middle income countries: a systematic review and meta-analysis.
    Ali HA; Hartner AM; Echeverria-Londono S; Roth J; Li X; Abbas K; Portnoy A; Vynnycky E; Woodruff K; Ferguson NM; Toor J; Gaythorpe KA
    Int J Equity Health; 2022 Jun; 21(1):82. PubMed ID: 35701823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.
    Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS
    Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users.
    O'Flaherty M; Lloyd-Williams F; Capewell S; Boland A; Maden M; Collins B; Bandosz P; Hyseni L; Kypridemos C
    Health Technol Assess; 2021 May; 25(35):1-234. PubMed ID: 34076574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A standardized approach for measuring multivariate equity in vaccination coverage, cost-of-illness, and health outcomes: Evidence from the Vaccine Economics Research for Sustainability & Equity (VERSE) project.
    Patenaude B; Odihi D; Sriudomporn S; Mak J; Watts E; de Broucker G
    Soc Sci Med; 2022 Jun; 302():114979. PubMed ID: 35462106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia.
    Dawkins BR; Mirelman AJ; Asaria M; Johansson KA; Cookson RA
    Health Policy Plan; 2018 Apr; 33(3):456-463. PubMed ID: 29309581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting immunization equity in Latin America and the Caribbean: Case studies, lessons learned, and their implication for COVID-19 vaccine equity.
    Chan IL; Mowson R; Alonso JP; Roberti J; Contreras M; Velandia-González M
    Vaccine; 2022 Mar; 40(13):1977-1986. PubMed ID: 35221122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa.
    Echeverria-Londono S; Hartner AM; Li X; Roth J; Portnoy A; Sbarra AN; Abbas K; Ferrari M; Fu H; Jit M; Ferguson NM; Gaythorpe KAM
    Vaccine; 2022 Nov; 40(47):6806-6817. PubMed ID: 36244882
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.